![]() |
市場調查報告書
商品編碼
1363988
全球微孔板系統市場 2023-2030Global Microplate Systems Market 2023-2030 |
預計在預測期內(2023-2030 年),全球微孔板系統市場將以 4.8% 的年複合成長率成長。市場成長歸因於對高通量篩選的需求不斷增加。酶標儀是進行快速、準確測試的重要設備,因此可用於藥物的發現和生產。因此,市場參與者正在推出新產品來滿足微型多模式酶標儀的需求。例如,2022 年 4 月,Molecular Devices, LLC. 和 Danaher Corp. 旗下公司推出了 SpectraMax Mini 多模式酶標儀。它是研究人員工作台上節省空間和金錢的工具。 SpectraMax Mini 讀板機足夠堅固,可滿足實驗室基本的微孔板讀板機需求,其小尺寸使其非常適合整合到具有多個儀器的大型工作站中。這台讀板機建立在該公司近四十年向市場提供高性能酶標儀技術的經驗之上。這些發展正在促進市場成長。
全球微孔板系統市場根據產品、應用和最終用戶進行細分。根據產品,市場細分為酶標儀、多模式酶標儀、基於濾光片的酶標儀、基於單色儀的酶標儀、混合酶標儀、單模式酶標儀、螢光酶標儀、吸光度酶標儀、發光酶標儀、微孔板移液系統和分配器、微孔板清洗機以及微孔板配件和軟體。根據應用,市場細分為藥物發現、臨床診斷、基因體學、蛋白質體學研究等。此外,根據最終用戶,市場細分為生物技術和製藥公司、醫院和診斷實驗室、學術和研究機構。在最終用戶中,由於政府對生物技術和製藥研究的資助增加,預計生物技術和製藥細分市場將佔據相當大的市場佔有率。
在這些產品中,微孔板讀板機細分市場預計將在全球微孔板系統市場中佔據相當大的佔有率。測試過程中對這些系統的高需求是促進細分市場成長的關鍵因素。 2023 年 8 月,Lonza 推出了 Nebula 吸光度讀數儀,這是一款新開發的吸光度微孔板讀數儀,擴展了該公司專為快速熱原和內毒素檢測而設計的設備陣容。 Nebula 吸光度讀數儀是一款高性能、技術增強的替代讀數儀,可產生與 ELx808 通常獲得的結果類似的結果,並使正在進行的熱原和內毒素測試程序變得更容易。
全球微孔板系統市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於患者數量的增加和診斷設施的增加推動了區域市場的成長,預計亞太地區將在全球市場中佔據顯著佔有率。
在所有地區中,北美地區預計在預測期內將以相當大的年複合成長率成長。區域成長歸因於醫療保健領域技術的不斷發展,公眾意識的提高預計將有助於預測期內的市場成長。此外,該地區許多國家的政府正在向衛生預算分配大量資金,以加強公共衛生和發展醫療基礎設施。例如,根據美國國立衛生研究院的數據,預計 2022 年美國將新增 1,918,030 例癌症病例,609,360 例癌症死亡。此外,肺癌是癌症死亡的主要原因,預計每天將導致約 350 人死亡。
服務微孔板系統市場的主要公司包括 Berthold Technologies GmbH & Co. KG、Bio-Rad Laboratories, Inc.、BMG LABTECH GmbH、Danaher Corp.、Harvard Bioscience, Inc. 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022 年 12 月,Molecular Devices, LLC 收購 Cellesce Ltd(「Cellesce」),鞏固了該公司作為 3D 生物解決方案先驅的地位。綜合知識大大加快了業界利用生理上適當的細胞模型進行藥物發現的速度。
Title: Global Microplate Systems Market Size, Share & Trends Analysis Report by Microplate Readers (Multi -Mode Readers, Filter-based Readers, Monochromator-based Readers, Hybrid readers, Single-Mode Microplate Readers, Fluorescence Plate Readers, Absorbance Plate Readers, Luminescence Plate Readers, Microplate Pipetting Systems and Dispensers, Microplate Washers, and Microplate Accessories & Software), by Application (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics Research, and Others), and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, and Academic & Research Institutes),Forecast Period (2023-2030).
The global microplate systems market is anticipated to grow at a considerable CAGR of 4.8% during the forecast period (2023-2030). The market growth is attributed to increasing demand for high-throughput screening. Microplate readers are essential devices that allow for rapid and accurate testing, and are therefore used in the discovery and production of drugs. Accordingly, market players are coming up with new products to cater the demand for mini multi-mode microplate reader. For instance, in April 2022, Molecular Devices, LLC., and a company of Danaher Corp. launched its SpectraMax Mini Multi-Mode Microplate Reader. It is a space- and money-saving tool for researchers' workbenches. The SpectraMax Mini reader is robust enough to meet a lab's essential microplate reader needs, and its small size makes it perfect for integration into a large workstation with multiple instruments. The reader is built on the company's nearly four decades of experience delivering high-performance microplate reader technology to the market. Such developments are contributing to the market growth.
The global microplate systems market is segmented based on the product, application, and end-user. Based on the product, the market is sub-segmented into microplate readers, multi-mode readers, filter-based readers, monochromator-based readers, hybrid readers, single-mode microplate readers, fluorescence plate readers, absorbance plate readers, luminescence plate readers, microplate pipetting systems and dispensers, microplate washers, and microplate accessories & software. Based on the applications, the market is sub-segmented into drug discovery, clinical diagnostics, genomics, proteomics research, and others. Further, on the basis of end-user, the market is sub-segmented into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, academic & research institutes. Among the end-user, the biotechnology & pharmaceutical sub-segment is anticipated to hold a considerable share of the market owing to the rise in government funding for biotech and pharma research.
Among the products, the microplate readers sub-segment is expected to hold a considerable share of the global microplate systems market. The high demand for these system during testing procedure is a key factor contributing to the segmental market growth. In August 2023, Lonza has launched the Nebula Absorbance Reader, a newly developed absorbance microplate reader that expands the business's lineup of devices designed for speedy pyrogen and endotoxin testing. The Nebula Absorbance Reader is a high-performance, technologically enhanced replacement reader that produces results similar to those commonly obtained with the ELx808 and makes it easier to carry out ongoing pyrogen and endotoxin testing programs.
The global microplate systems market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing numbers of patients and an increase in diagnostic facilities that are driving regional market growth.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing technological developments in the healthcare sector and heightened public awareness are expected to contribute to market growth during the forecast period. Additionally, governments in numerous countries across the region are allocating substantial funds to health budgets to enhance public health and develop healthcare infrastructure facilities. For instance, according to the National Institute of Health, in 2022, it is estimated that 1,918,030 new cancer cases and 609,360 cancer deaths occur in the US. Additionally, lung cancer, that is the leading cause of cancer death, is projected to cause around 350 deaths per day.
The major companies serving the Microplate Systems market include Berthold Technologies GmbH & Co. KG, Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Danaher Corp., Harvard Bioscience, Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, the acquisition of Cellesce Ltd ("Cellesce") by Molecular Devices, LLC strengthens the company's position as a pioneer in 3D biology solutions. Combined knowledge substantially speeds up the industry's utilization of physiologically appropriate cell models for drug discovery.